NEW YORK – Which articles gained the most attention from GenomeWeb's readers last week? Here are the top five:
- NeoGenomics Details Plans for New NGS Oncology Tests as Q2 Revenues Continue to Climb
- Spear Bio Raises $45M in Series A Round for Protein-Based Diagnostics Using qPCR Instruments
- Guardant Health's Shield Test Approved by FDA as Primary Blood-Based CRC Screening Option
- Labcorp, Ultima Genomics Collaborate on NGS-Based Cancer Testing
- Fluent BioSciences Deal Again Puts Illumina in Competition With NGS Assay Developers